Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization
To access this article, please choose from the options below
FDA device/drug status: not applicable.
Author disclosures: none.
PII: S1529-9430(09)00812-2
doi:10.1016/j.spinee.2009.08.447
Published by Elsevier Inc.
